177Lu-TLX250

TLX250 · Telix Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for 177Lu-TLX250, covering 2024-05-01 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC [Phase 3]